Publications by authors named "Bruno S Salle"
Article Synopsis
- Corifollitropin alfa is a single-injection treatment that replaces seven daily FSH injections in controlled ovarian stimulation (COS) cycles and was tested for safety and immunogenicity.
- A study involved 682 patients starting their first cycle, with no significant immune reactions or hypersensitivity to the drug reported, and side effects included procedural pain, headaches, and pelvic discomfort.
- After three cycles, the cumulative pregnancy rate was 61%, indicating that corifollitropin alfa is a safe and effective option for ovarian stimulation without immunogenicity concerns.
